Benserazide Completed Phase 3 Trials for Restless Legs Syndrome (RLS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00144209Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (MadoparĀ® DR) in Patients With Restless Legs Syndrome